Plasmonic Biosensors for the Detection of Lung Cancer Biomarkers: A Review

Lung cancer is the most common and deadliest cancer type globally. Its early diagnosis can guarantee a five-year survival rate. Unfortunately, application of the available diagnosis methods such as computed tomography, chest radiograph, magnetic resonance imaging (MRI), ultrasound, low-dose CT scan,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fahad Usman, John Ojur Dennis, A.I. Aljameel, M.K.M. Ali, O. Aldaghri, K.H. Ibnaouf, Zakariyya Uba Zango, Mahnoush Beygisangchin, Ahmed Alsadig, Fabrice Meriaudeau
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/1c03a2d5aca74cbd8866942f25882066
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1c03a2d5aca74cbd8866942f25882066
record_format dspace
spelling oai:doaj.org-article:1c03a2d5aca74cbd8866942f258820662021-11-25T17:13:44ZPlasmonic Biosensors for the Detection of Lung Cancer Biomarkers: A Review10.3390/chemosensors91103262227-9040https://doaj.org/article/1c03a2d5aca74cbd8866942f258820662021-11-01T00:00:00Zhttps://www.mdpi.com/2227-9040/9/11/326https://doaj.org/toc/2227-9040Lung cancer is the most common and deadliest cancer type globally. Its early diagnosis can guarantee a five-year survival rate. Unfortunately, application of the available diagnosis methods such as computed tomography, chest radiograph, magnetic resonance imaging (MRI), ultrasound, low-dose CT scan, bone scans, positron emission tomography (PET), and biopsy is hindered due to one or more problems, such as phenotypic properties of tumours that prevent early detection, invasiveness, expensiveness, and time consumption. Detection of lung cancer biomarkers using a biosensor is reported to solve the problems. Among biosensors, optical biosensors attract greater attention due to being ultra-sensitive, free from electromagnetic interference, capable of wide dynamic range detection, free from the requirement of a reference electrode, free from electrical hazards, highly stable, capable of multiplexing detection, and having the potential for more information content than electrical transducers. Inspired by promising features of plasmonic sensors, including surface plasmon resonance (SPR), localised surface plasmon resonance (LSPR), and surface enhanced Raman scattering (SERS) such as ultra-sensitivity, single particle/molecular level detection capability, multiplexing capability, photostability, real-time measurement, label-free measurement, room temperature operation, naked-eye readability, and the ease of miniaturisation without sophisticated sensor chip fabrication and instrumentation, numerous plasmonic sensors for the detection of lung cancer biomarkers have been investigated. In this review, the principle plasmonic sensor is explained. In addition, novel strategies and modifications adopted for the detection of lung cancer biomarkers such as miRNA, carcinoembryonic antigen (CEA), cytokeratins, and volatile organic compounds (VOCs) using plasmonic sensors are also reported. Furthermore, the challenges and prospects of the plasmonic biosensors for the detection of lung cancer biomarkers are highlighted.Fahad UsmanJohn Ojur DennisA.I. AljameelM.K.M. AliO. AldaghriK.H. IbnaoufZakariyya Uba ZangoMahnoush BeygisangchinAhmed AlsadigFabrice MeriaudeauMDPI AGarticleplasmonic biosensorslung cancerbiomarkerssurface plasmon resonancesurface enhanced Raman scatteringlocalised surface plasmon resonanceBiochemistryQD415-436ENChemosensors, Vol 9, Iss 326, p 326 (2021)
institution DOAJ
collection DOAJ
language EN
topic plasmonic biosensors
lung cancer
biomarkers
surface plasmon resonance
surface enhanced Raman scattering
localised surface plasmon resonance
Biochemistry
QD415-436
spellingShingle plasmonic biosensors
lung cancer
biomarkers
surface plasmon resonance
surface enhanced Raman scattering
localised surface plasmon resonance
Biochemistry
QD415-436
Fahad Usman
John Ojur Dennis
A.I. Aljameel
M.K.M. Ali
O. Aldaghri
K.H. Ibnaouf
Zakariyya Uba Zango
Mahnoush Beygisangchin
Ahmed Alsadig
Fabrice Meriaudeau
Plasmonic Biosensors for the Detection of Lung Cancer Biomarkers: A Review
description Lung cancer is the most common and deadliest cancer type globally. Its early diagnosis can guarantee a five-year survival rate. Unfortunately, application of the available diagnosis methods such as computed tomography, chest radiograph, magnetic resonance imaging (MRI), ultrasound, low-dose CT scan, bone scans, positron emission tomography (PET), and biopsy is hindered due to one or more problems, such as phenotypic properties of tumours that prevent early detection, invasiveness, expensiveness, and time consumption. Detection of lung cancer biomarkers using a biosensor is reported to solve the problems. Among biosensors, optical biosensors attract greater attention due to being ultra-sensitive, free from electromagnetic interference, capable of wide dynamic range detection, free from the requirement of a reference electrode, free from electrical hazards, highly stable, capable of multiplexing detection, and having the potential for more information content than electrical transducers. Inspired by promising features of plasmonic sensors, including surface plasmon resonance (SPR), localised surface plasmon resonance (LSPR), and surface enhanced Raman scattering (SERS) such as ultra-sensitivity, single particle/molecular level detection capability, multiplexing capability, photostability, real-time measurement, label-free measurement, room temperature operation, naked-eye readability, and the ease of miniaturisation without sophisticated sensor chip fabrication and instrumentation, numerous plasmonic sensors for the detection of lung cancer biomarkers have been investigated. In this review, the principle plasmonic sensor is explained. In addition, novel strategies and modifications adopted for the detection of lung cancer biomarkers such as miRNA, carcinoembryonic antigen (CEA), cytokeratins, and volatile organic compounds (VOCs) using plasmonic sensors are also reported. Furthermore, the challenges and prospects of the plasmonic biosensors for the detection of lung cancer biomarkers are highlighted.
format article
author Fahad Usman
John Ojur Dennis
A.I. Aljameel
M.K.M. Ali
O. Aldaghri
K.H. Ibnaouf
Zakariyya Uba Zango
Mahnoush Beygisangchin
Ahmed Alsadig
Fabrice Meriaudeau
author_facet Fahad Usman
John Ojur Dennis
A.I. Aljameel
M.K.M. Ali
O. Aldaghri
K.H. Ibnaouf
Zakariyya Uba Zango
Mahnoush Beygisangchin
Ahmed Alsadig
Fabrice Meriaudeau
author_sort Fahad Usman
title Plasmonic Biosensors for the Detection of Lung Cancer Biomarkers: A Review
title_short Plasmonic Biosensors for the Detection of Lung Cancer Biomarkers: A Review
title_full Plasmonic Biosensors for the Detection of Lung Cancer Biomarkers: A Review
title_fullStr Plasmonic Biosensors for the Detection of Lung Cancer Biomarkers: A Review
title_full_unstemmed Plasmonic Biosensors for the Detection of Lung Cancer Biomarkers: A Review
title_sort plasmonic biosensors for the detection of lung cancer biomarkers: a review
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/1c03a2d5aca74cbd8866942f25882066
work_keys_str_mv AT fahadusman plasmonicbiosensorsforthedetectionoflungcancerbiomarkersareview
AT johnojurdennis plasmonicbiosensorsforthedetectionoflungcancerbiomarkersareview
AT aialjameel plasmonicbiosensorsforthedetectionoflungcancerbiomarkersareview
AT mkmali plasmonicbiosensorsforthedetectionoflungcancerbiomarkersareview
AT oaldaghri plasmonicbiosensorsforthedetectionoflungcancerbiomarkersareview
AT khibnaouf plasmonicbiosensorsforthedetectionoflungcancerbiomarkersareview
AT zakariyyaubazango plasmonicbiosensorsforthedetectionoflungcancerbiomarkersareview
AT mahnoushbeygisangchin plasmonicbiosensorsforthedetectionoflungcancerbiomarkersareview
AT ahmedalsadig plasmonicbiosensorsforthedetectionoflungcancerbiomarkersareview
AT fabricemeriaudeau plasmonicbiosensorsforthedetectionoflungcancerbiomarkersareview
_version_ 1718412574895112192